Ohr Pharmaceuticals (NASDAQ:OHRP) Upgraded by ValuEngine to Sell

Retrieved on: 2017-12-13 02:00:00

Tags for this article:

Economy

Short

Financial regulation

OHR PHARMACEUTICAL , INC

Ohr Pharmaceuticals

Click the tags to see associated articles and topics

Ohr Pharmaceuticals (NASDAQ:OHRP) Upgraded by ValuEngine to Sell. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC raised its stake in shares of Ohr Pharmaceuticals by 242.3% in the first quarter. <b>Renaissance Technologies</b> LLC now owns 229,709 shares of the biotechnology company's stock worth $191,000 after acquiring an additional 162,600 shares during the last quarter. Cannell ...</div>

Article found on:

View Original Article